Related Experiment Video
Updated: Jun 5, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Measuring cancer clinical trial understanding.
Jon D Miller1, Michael R Kotowski, Robert L Comis
1Institute for Social Research, University of Michigan, Ann Arbor, MI 48823, USA. jondmiller@umich.edu
Health Communication
|January 11, 2011
Summary
A new measure assesses understanding of cancer clinical trials, crucial for ethical recruitment and informed decisions. This validated tool aids researchers and patients in navigating trial participation.
Area of Science:
- Health Communication
- Clinical Trials Research
- Patient Education
Background:
- Effective participation in cancer clinical trials requires clear patient understanding.
- Ethical recruitment and informed decision-making depend on comprehension of trial processes.
- A validated measure for cancer clinical trial understanding was previously unavailable.
Purpose of the Study:
- To introduce a valid and reliable measure of cancer clinical trial understanding.
- To detail the measure's development, rationale, and psychometric properties.
- To examine the relationship between trial understanding and enrollment decisions.
Main Methods:
- Development of a measure based on a 2005 study for the Coalition of Cooperative Cancer Groups.
- Psychometric evaluation including validity and reliability assessments.
- Analysis of data from national samples of cancer survivors and the general public.
Main Results:
- The developed measure demonstrated strong validity and reliability.
- Data confirmed the measure's effectiveness across diverse populations.
- A significant relationship was found between understanding and enrollment decisions.
Conclusions:
- The new measure provides a reliable tool for assessing cancer clinical trial comprehension.
- Improved patient understanding can enhance informed decision-making in clinical trial participation.
- Findings have implications for health communication strategies in oncology research.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...